-
1
-
-
57249098943
-
The barrier of hypoglycemia in diabetes
-
Cryer PE. The barrier of hypoglycemia in diabetes. Diabetes (2008); 57:3169-76
-
(2008)
Diabetes
, vol.57
, pp. 3169-3176
-
-
Cryer, P.E.1
-
2
-
-
74549169228
-
Pharmacologic management of the older patient with type 2 diabetes mellitus
-
Neumiller JJ, Setter SM. Pharmacologic management of the older patient with type 2 diabetes mellitus. Am J Geriatr Pharmacother (2009);7:324-42
-
(2009)
Am J Geriatr Pharmacother
, vol.7
, pp. 324-342
-
-
Neumiller, J.J.1
Setter, S.M.2
-
3
-
-
0037968349
-
Guidelines for improving the care of the older person with diabetes mellitus
-
Brown AF, Mangione CM, Saliba D, et al. Guidelines for improving the care of the older person with diabetes mellitus. J Am Geriatr Soc (2003);51:S265-80
-
(2003)
J Am Geriatr Soc
, vol.51
-
-
Brown, A.F.1
Mangione, C.M.2
Saliba, D.3
-
4
-
-
84862833218
-
Correlates of quality of life in older adults with diabetes: The diabetes & aging study
-
Laiteerapong N, Karter AJ, Liu JY, et al. Correlates of quality of life in older adults with diabetes: the diabetes & aging study. Diabetes Care (2011);34:1749-53
-
(2011)
Diabetes Care
, vol.34
, pp. 1749-1753
-
-
Laiteerapong, N.1
Karter, A.J.2
Liu, J.Y.3
-
5
-
-
79960560204
-
Assessment of severity and frequency of self-reported hypoglycemia on quality of life in patients with type 2 diabetes treated with oral antihyperglycemic agents: A survey study
-
Marrett E, Radican L, Davies MJ, et al. Assessment of severity and frequency of self-reported hypoglycemia on quality of life in patients with type 2 diabetes treated with oral antihyperglycemic agents: A survey study. BMC Res Notes (2011);4:251
-
(2011)
BMC Res Notes
, vol.4
, pp. 251
-
-
Marrett, E.1
Radican, L.2
Davies, M.J.3
-
6
-
-
74849099588
-
Patient-reported tolerability issues with oral antidiabetic agents: Associations with adherence; Treatment satisfaction and health-related quality of life
-
Pollack MF, Purayidathil FW, Bolge SC, et al. Patient-reported tolerability issues with oral antidiabetic agents: Associations with adherence; treatment satisfaction and health-related quality of life. Diabetes Res Clin Pract (2010);87:204-10
-
(2010)
Diabetes Res Clin Pract
, vol.87
, pp. 204-210
-
-
Pollack, M.F.1
Purayidathil, F.W.2
Bolge, S.C.3
-
7
-
-
74949117631
-
The association between symptomatic, severe hypoglycaemia and mortality in type 2 diabetes: Retrospective epidemiological analysis of the ACCORD study
-
Bonds DE, Miller ME, Bergenstal RM, et al. The association between symptomatic, severe hypoglycaemia and mortality in type 2 diabetes: retrospective epidemiological analysis of the ACCORD study. BMJ (2010);340:b4909
-
(2010)
BMJ
, vol.340
-
-
Bonds, D.E.1
Miller, M.E.2
Bergenstal, R.M.3
-
8
-
-
79956095353
-
Evidence linking hypoglycemic events to an increased risk of acute cardiovascular events in patients with type 2 diabetes
-
Johnston SS, Conner C, Aagren M, et al. Evidence linking hypoglycemic events to an increased risk of acute cardiovascular events in patients with type 2 diabetes. Diabetes Care (2011);34:1164-70
-
(2011)
Diabetes Care
, vol.34
, pp. 1164-1170
-
-
Johnston, S.S.1
Conner, C.2
Aagren, M.3
-
10
-
-
77955492704
-
The case for hypoglycaemia as a proarrhythmic event: Basic and clinical evidence
-
Nordin C. The case for hypoglycaemia as a proarrhythmic event: basic and clinical evidence. Diabetologia (2010);53:1552-61
-
(2010)
Diabetologia
, vol.53
, pp. 1552-1561
-
-
Nordin, C.1
-
11
-
-
27844556869
-
The economic and quality of life impact of hypoglycemia
-
Lundkvist J, Berne C, Bolinder B, et al. The economic and quality of life impact of hypoglycemia. Eur J Health Econ (2005);6:197-202
-
(2005)
Eur J Health Econ
, vol.6
, pp. 197-202
-
-
Lundkvist, J.1
Berne, C.2
Bolinder, B.3
-
12
-
-
33646252953
-
Cost of hypoglycemia in patients with type 2 diabetes in Sweden
-
Jonsson L, Bolinder B, Lundkvist J. Cost of hypoglycemia in patients with type 2 diabetes in Sweden. Value Health (2006);9:193-8
-
(2006)
Value Health
, vol.9
, pp. 193-198
-
-
Jonsson, L.1
Bolinder, B.2
Lundkvist, J.3
-
13
-
-
64349083605
-
Diabetes prevalence and therapeutic target achievement in the United States, (1999) to (2006)
-
Cheung BM, Ong KL, Cherny SS, et al. Diabetes prevalence and therapeutic target achievement in the United States, (1999) to (2006). Am J Med (2009);122:443-53
-
(2009)
Am J Med
, vol.122
, pp. 443-453
-
-
Cheung, B.M.1
Ong, K.L.2
Cherny, S.S.3
-
14
-
-
34247113679
-
Undertreatment of cardiovascular risk factors among persons with diabetes in the United States
-
Malik S, Lopez V, Chen R, et al. Undertreatment of cardiovascular risk factors among persons with diabetes in the United States. Diabetes Res Clin Pract (2007);77:126-33
-
(2007)
Diabetes Res Clin Pract
, vol.77
, pp. 126-133
-
-
Malik, S.1
Lopez, V.2
Chen, R.3
-
15
-
-
1542618210
-
Hypoglycemia as a barrier to glycemic control
-
Davis S, Alonso MD. Hypoglycemia as a barrier to glycemic control. J Diabetes Complications (2004);18:60-8
-
(2004)
J Diabetes Complications
, vol.18
, pp. 60-68
-
-
Davis, S.1
Alonso, M.D.2
-
16
-
-
77958047126
-
Intensified glucose lowering in type 2 diabetes: Time for a reappraisal
-
Yudkin JS, Richter B, Gale EA. Intensified glucose lowering in type 2 diabetes: time for a reappraisal. Diabetologia (2010);53:2079-85
-
(2010)
Diabetologia
, vol.53
, pp. 2079-2085
-
-
Yudkin, J.S.1
Richter, B.2
Gale, E.A.3
-
17
-
-
60449089649
-
Medical management of hyperglycemia in type 2 diabetes: A consensus algorithm for the initiation and adjustment of therapy: A consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes
-
Nathan DM, Buse JB, Davidson MB, et al. Medical management of hyperglycemia in type 2 diabetes: A consensus algorithm for the initiation and adjustment of therapy: A consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care (2009);32:193-203
-
(2009)
Diabetes Care
, vol.32
, pp. 193-203
-
-
Nathan, D.M.1
Buse, J.B.2
Davidson, M.B.3
-
18
-
-
79953787446
-
What to add in with metformin in type 2 diabetes?
-
Petrie JR, Adler A, Vella S. What to add in with metformin in type 2 diabetes? QJM (2011);104:185-92
-
(2011)
QJM
, vol.104
, pp. 185-192
-
-
Petrie, J.R.1
Adler, A.2
Vella, S.3
-
19
-
-
0037116638
-
Oral antihyperglycemic therapy for type 2 diabetes: Scientific review
-
Inzucchi SE. Oral antihyperglycemic therapy for type 2 diabetes: scientific review. JAMA (2002);287:360-72
-
(2002)
JAMA
, vol.287
, pp. 360-372
-
-
Inzucchi, S.E.1
-
20
-
-
34249902025
-
Dipeptidyl peptidase-4 inhibition and the treatment of type 2 diabetes: Preclinical biology and mechanisms of action
-
Drucker DJ. Dipeptidyl peptidase-4 inhibition and the treatment of type 2 diabetes: preclinical biology and mechanisms of action. Diabetes Care (2007);30:1335-43
-
(2007)
Diabetes Care
, vol.30
, pp. 1335-1343
-
-
Drucker, D.J.1
-
21
-
-
33846817233
-
Efficacy and safety of the dipeptidyl peptidase-4 inhibitor, sitagliptin, compared with the sulfonylurea, glipizide, in patients with type 2 diabetes inadequately controlled on metformin alone: A randomized, double-blind, non-inferiority trial
-
Nauck MA, Meininger G, Sheng D, et al. Efficacy and safety of the dipeptidyl peptidase-4 inhibitor, sitagliptin, compared with the sulfonylurea, glipizide, in patients with type 2 diabetes inadequately controlled on metformin alone: A randomized, double-blind, non-inferiority trial. Diabetes Obes Metab (2007);9:194-205
-
(2007)
Diabetes Obes Metab
, vol.9
, pp. 194-205
-
-
Nauck, M.A.1
Meininger, G.2
Sheng, D.3
-
22
-
-
77949387699
-
Safety and efficacy of treatment with sitagliptin or glipizide in patients with type 2 diabetes inadequately controlled on metformin: A 2-year study
-
Seck T, Nauck MA, Sheng D, et al. Safety and efficacy of treatment with sitagliptin or glipizide in patients with type 2 diabetes inadequately controlled on metformin: A 2-year study. Int J Clin Pract (2010);64:562-76
-
(2010)
Int J Clin Pract
, vol.64
, pp. 562-576
-
-
Seck, T.1
Nauck, M.A.2
Sheng, D.3
-
23
-
-
78650656671
-
Efficacy and safety of treatment with sitagliptin or glimepiride in patients with type 2 diabetes inadequately controlled on metformin monotherapy: A randomized, double-blind, non-inferiority trial
-
Arechavaleta R, Seck T, Chen Y, et al. Efficacy and safety of treatment with sitagliptin or glimepiride in patients with type 2 diabetes inadequately controlled on metformin monotherapy: A randomized, double-blind, non-inferiority trial. Diabetes Obes Metab (2011);13:160-8
-
(2011)
Diabetes Obes Metab
, vol.13
, pp. 160-168
-
-
Arechavaleta, R.1
Seck, T.2
Chen, Y.3
-
24
-
-
34848813157
-
Negative binomial meta-regression analysis of combined glycosylated hemoglobin and hypoglycemia outcomes across eleven Phase III and IV studies of insulin glargine compared with neutral protamine Hagedorn insulin in type 1 and type 2 diabetes mellitus
-
Mullins P, Sharplin P, Yki-Jarvinen H, et al. Negative binomial meta-regression analysis of combined glycosylated hemoglobin and hypoglycemia outcomes across eleven Phase III and IV studies of insulin glargine compared with neutral protamine Hagedorn insulin in type 1 and type 2 diabetes mellitus. Clin Ther (2007);29:1607-19
-
(2007)
Clin Ther
, vol.29
, pp. 1607-1619
-
-
Mullins, P.1
Sharplin, P.2
Yki-Jarvinen, H.3
-
25
-
-
18144388647
-
Defining and reporting hypoglycemia in diabetes: A report from the American Diabetes Association Workgroup on Hypoglycemia
-
American Diabetes Association Workgroup on Hypoglycemia
-
American Diabetes Association Workgroup on Hypoglycemia. Defining and reporting hypoglycemia in diabetes: A report from the American Diabetes Association Workgroup on Hypoglycemia. Diabetes Care (2005);28:1245-9
-
(2005)
Diabetes Care
, vol.28
, pp. 1245-1249
-
-
-
26
-
-
77951069227
-
Safety and tolerability of sitagliptin in clinical studies: A pooled analysis of data from 10,246 patients with type 2 diabetes
-
Williams-Herman D, Engel SS, Round E, et al. Safety and tolerability of sitagliptin in clinical studies: A pooled analysis of data from 10,246 patients with type 2 diabetes. BMC Endocr Disord (2010);10:7
-
(2010)
BMC Endocr Disord
, vol.10
, pp. 7
-
-
Williams-Herman, D.1
Engel, S.S.2
Round, E.3
-
27
-
-
33644817974
-
Hypoglycemia in type 2 diabetes: Pathophysiology, frequency, and effects of different treatment modalities
-
Zammitt NN, Frier BM. Hypoglycemia in type 2 diabetes: pathophysiology, frequency, and effects of different treatment modalities. Diabetes Care (2005);28:2948-61
-
(2005)
Diabetes Care
, vol.28
, pp. 2948-2961
-
-
Zammitt, N.N.1
Frier, B.M.2
-
28
-
-
0031024007
-
Altered hierarchy of protective responses against severe hypoglycemia in normal aging in healthy men
-
Matyka K, Evans M, Lomas J, et al. Altered hierarchy of protective responses against severe hypoglycemia in normal aging in healthy men. Diabetes Care (1997);20:135-41
-
(1997)
Diabetes Care
, vol.20
, pp. 135-141
-
-
Matyka, K.1
Evans, M.2
Lomas, J.3
-
29
-
-
0033667959
-
Differential gender responses to hypoglycemia are due to alterations in CNS drive and not glycemic thresholds
-
Davis SN, Shavers C, Costa F. Differential gender responses to hypoglycemia are due to alterations in CNS drive and not glycemic thresholds. Am J Physiol Endocrinol Metab (2000);279:E1054-63
-
(2000)
Am J Physiol Endocrinol Metab
, vol.279
-
-
Davis, S.N.1
Shavers, C.2
Costa, F.3
-
30
-
-
0027144999
-
Gender influences counterregulatory hormone responses to hypoglycemia
-
Diamond MP, Jones T, Caprio S, et al. Gender influences counterregulatory hormone responses to hypoglycemia. Metabolism (1993);42:1568-72
-
(1993)
Metabolism
, vol.42
, pp. 1568-1572
-
-
Diamond, M.P.1
Jones, T.2
Caprio, S.3
-
31
-
-
0027229299
-
Gender differences in counterregulation to hypoglycaemia
-
Amiel SA, Maran A, Powrie JK, et al. Gender differences in counterregulation to hypoglycaemia. Diabetologia (1993);36:460-4
-
(1993)
Diabetologia
, vol.36
, pp. 460-464
-
-
Amiel, S.A.1
Maran, A.2
Powrie, J.K.3
-
32
-
-
74949138626
-
The effects of baseline characteristics, glycaemia treatment approach, and glycated haemoglobin concentration on the risk of severe hypoglycaemia: Post hoc epidemiological analysis of the ACCORD study
-
Miller ME, Bonds DE, Gerstein HC, et al. The effects of baseline characteristics, glycaemia treatment approach, and glycated haemoglobin concentration on the risk of severe hypoglycaemia: post hoc epidemiological analysis of the ACCORD study. BMJ (2010);340:b5444
-
(2010)
BMJ
, vol.340
-
-
Miller, M.E.1
Bonds, D.E.2
Gerstein, H.C.3
-
33
-
-
79251567403
-
Serious cardiovascular outcomes in diabetes: The role of hypoglycemia
-
Yakubovich N, Gerstein HC. Serious cardiovascular outcomes in diabetes: the role of hypoglycemia. Circulation (2011);123:342-8
-
(2011)
Circulation
, vol.123
, pp. 342-348
-
-
Yakubovich, N.1
Gerstein, H.C.2
-
34
-
-
49449109529
-
Vascular disease and diabetes: Is hypoglycaemia an aggravating factor?
-
Wright RJ, Frier BM. Vascular disease and diabetes: is hypoglycaemia an aggravating factor? Diabetes Metab Res Rev (2008);24:353-63
-
(2008)
Diabetes Metab Res Rev
, vol.24
, pp. 353-363
-
-
Wright, R.J.1
Frier, B.M.2
-
35
-
-
0014914649
-
A study of the effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. II. Mortality results
-
Meinert CL, Knatterud GL, Prout TE, et al. A study of the effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. II. Mortality results. Diabetes (1970);19:789-815
-
(1970)
Diabetes
, vol.19
, pp. 789-815
-
-
Meinert, C.L.1
Knatterud, G.L.2
Prout, T.E.3
-
36
-
-
67349203256
-
The risk of developing coronary artery disease or congestive heart failure, and overall mortality, in type 2 diabetic patients receiving rosiglitazone, pioglitazone, metformin, or sulfonylureas: A retrospective analysis
-
Pantalone KM, Kattan MW, Yu C, et al. The risk of developing coronary artery disease or congestive heart failure, and overall mortality, in type 2 diabetic patients receiving rosiglitazone, pioglitazone, metformin, or sulfonylureas: A retrospective analysis. Acta Diabetol (2009);46:145-54
-
(2009)
Acta Diabetol
, vol.46
, pp. 145-154
-
-
Pantalone, K.M.1
Kattan, M.W.2
Yu, C.3
-
37
-
-
33646422782
-
Risk of mortality and adverse cardiovascular outcomes in type 2 diabetes: A comparison of patients treated with sulfonylureas and metformin
-
Evans JM, Ogston SA, Emslie-Smith A, et al. Risk of mortality and adverse cardiovascular outcomes in type 2 diabetes: A comparison of patients treated with sulfonylureas and metformin. Diabetologia (2006); 49:930-6
-
(2006)
Diabetologia
, vol.49
, pp. 930-936
-
-
Evans, J.M.1
Ogston, S.A.2
Emslie-Smith, A.3
-
38
-
-
0038279359
-
Decreased mortality associated with the use of metformin compared with sulfonylurea monotherapy in type 2 diabetes
-
Johnson JA, Majumdar SR, Simpson SH, et al. Decreased mortality associated with the use of metformin compared with sulfonylurea monotherapy in type 2 diabetes. Diabetes Care (2002);25:2244-8
-
(2002)
Diabetes Care
, vol.25
, pp. 2244-2248
-
-
Johnson, J.A.1
Majumdar, S.R.2
Simpson, S.H.3
-
39
-
-
79958197888
-
Mortality and cardiovascular risk associated with different insulin secretagogues compared with metformin in type 2 diabetes, with or without a previous myocardial infarction: A nationwide study
-
Schramm TK, Gislason GH, Vaag A, et al. Mortality and cardiovascular risk associated with different insulin secretagogues compared with metformin in type 2 diabetes, with or without a previous myocardial infarction: A nationwide study. Eur Heart J (2011);32:1900-8
-
(2011)
Eur Heart J
, vol.32
, pp. 1900-1908
-
-
Schramm, T.K.1
Gislason, G.H.2
Vaag, A.3
-
40
-
-
17144384777
-
Reduced cardiovascular morbidity and mortality associated with metformin use in subjects with type 2 diabetes
-
Johnson JA, Simpson SH, Toth EL, et al. Reduced cardiovascular morbidity and mortality associated with metformin use in subjects with type 2 diabetes. Diabet Med (2005);22:497-502
-
(2005)
Diabet Med
, vol.22
, pp. 497-502
-
-
Johnson, J.A.1
Simpson, S.H.2
Toth, E.L.3
-
41
-
-
84860117993
-
Risk of cardiovascular disease and all cause mortality among patients with type 2 diabetes prescribed oral antidiabetes drugs: Retrospective cohort study using UK general practice research database
-
Tzoulaki I, Molokhia M, Curcin V, et al. Risk of cardiovascular disease and all cause mortality among patients with type 2 diabetes prescribed oral antidiabetes drugs: retrospective cohort study using UK general practice research database. BMJ (2009);339:b4731
-
(2009)
BMJ
, vol.339
-
-
Tzoulaki, I.1
Molokhia, M.2
Curcin, V.3
-
42
-
-
78649315767
-
Metformin treatment is associated with a low risk of mortality in diabetic patients with heart failure: A retrospective nationwide cohort study
-
Andersson C, Olesen JB, Hansen PR, et al. Metformin treatment is associated with a low risk of mortality in diabetic patients with heart failure: A retrospective nationwide cohort study. Diabetologia (2010);53:2546-53
-
(2010)
Diabetologia
, vol.53
, pp. 2546-2553
-
-
Andersson, C.1
Olesen, J.B.2
Hansen, P.R.3
-
43
-
-
84872830635
-
Cardiovascular safety of sitagliptin versus a sulphonylurea in patients with type 2 diabetes mellitus: A pooled analysis (abstract)
-
Presented at the Dubai, UAE
-
Goldstein BJ, Engel SS, Golm GT, et al. Cardiovascular safety of sitagliptin versus a sulphonylurea in patients with type 2 diabetes mellitus: A pooled analysis (abstract). Presented at the (2011) International Diabetes Federation meeting, Dubai, UAE
-
(2011)
International Diabetes Federation Meeting
-
-
Goldstein, B.J.1
Engel, S.S.2
Golm, G.T.3
|